Retinol-binding protein 4 (RBP4) as the causative factor and marker of vascular injury related to insulin resistance
- PMID: 28026829
Retinol-binding protein 4 (RBP4) as the causative factor and marker of vascular injury related to insulin resistance
Abstract
One of adipokines involved in the development of insulin resistance is retinol-binding protein 4(RBP4). The physiological role of RBP4 is transport of retinol from the liver to peripheral tissues. One of the first events related to the excessive visceral fat accumulation is the development of inflammation followed by hormonal adipose tissue dysfunction, including excessive RBP4 production. Reduced density of the membrane-type glucose transporter 4 (GLUT4) is considered as a direct cause for the stimulation of RBP4 release to the circulation by adipocytes. Circulating RBP4 inhibits the signal pathways stimulated by insulin in skeletal muscle cells, resulting in the development of insulin resistance. Drugs stimulating receptor peroxisome proliferator-activated gamma (PPARγ) - thiazolidinediones - inhibit the production of RBP4 by adipose tissue and increase the insulin sensitivity of the tissues. Increased secretion of RBP4 stimulates the expression of adhesion molecules in the endothelial cells, promoting development of atherosclerosis and arterial hypertension. Population studies demonstrated an association between serum RBP4 in the circulation, and the severity of atherosclerosis and risk of the cardiovascular events and type 2 diabetes. It also appears that the rbp4 gene functional polymorphisms may influence the risk of metabolic complications of obesity, including vascular injury. Therefore, the concentration of RBP4 in the circulation may be considered both as the causative factor and marker of chronic vascular injury. This article summarizes the current state of knowledge on the potential role of RBP4 in the pathogenesis of cardiovascular diseases, particularly related to insulin resistance.
Similar articles
-
Serum retinol-binding protein: a link between obesity, insulin resistance, and type 2 diabetes.Nutr Rev. 2007 May;65(5):251-6. doi: 10.1111/j.1753-4887.2007.tb00302.x. Nutr Rev. 2007. PMID: 17566551 Review.
-
Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone.J Clin Endocrinol Metab. 2007 Jul;92(7):2590-7. doi: 10.1210/jc.2006-0816. Epub 2007 Jun 26. J Clin Endocrinol Metab. 2007. PMID: 17595259 Free PMC article.
-
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.Nature. 2005 Jul 21;436(7049):356-62. doi: 10.1038/nature03711. Nature. 2005. PMID: 16034410
-
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.N Engl J Med. 2006 Jun 15;354(24):2552-63. doi: 10.1056/NEJMoa054862. N Engl J Med. 2006. PMID: 16775236
-
Interplay of retinol binding protein 4 with obesity and associated chronic alterations (Review).Mol Med Rep. 2022 Jul;26(1):244. doi: 10.3892/mmr.2022.12760. Epub 2022 Jun 3. Mol Med Rep. 2022. PMID: 35656886 Free PMC article. Review.
Cited by
-
Changes of serum retinol-binding protein 4 associated with improved insulin resistance after laparoscopic sleeve gastrectomy in Chinese obese patients.Diabetol Metab Syndr. 2020 Jan 14;12:7. doi: 10.1186/s13098-019-0511-1. eCollection 2020. Diabetol Metab Syndr. 2020. PMID: 31956345 Free PMC article.
-
Obesity and obesity-induced inflammatory disease contribute to atherosclerosis: a review of the pathophysiology and treatment of obesity.Am J Cardiovasc Dis. 2021 Aug 15;11(4):504-529. eCollection 2021. Am J Cardiovasc Dis. 2021. PMID: 34548951 Free PMC article. Review.
-
Association between Retinol-Binding Protein 4 Levels and Preeclampsia: A Systematic Review and Meta-Analysis.Nutrients. 2022 Dec 7;14(24):5201. doi: 10.3390/nu14245201. Nutrients. 2022. PMID: 36558360 Free PMC article. Review.
-
Dapagliflozin treatment and cardiovascular outcome in RBP4/TTRVal30Met (transthyretin cardiac amyloidosis) mice.ESC Heart Fail. 2024 Feb;11(1):179-188. doi: 10.1002/ehf2.14567. Epub 2023 Oct 25. ESC Heart Fail. 2024. PMID: 37877450 Free PMC article.
-
Emerging Protein Biomarkers for the Diagnosis or Prediction of Gestational Diabetes-A Scoping Review.J Clin Med. 2021 Apr 6;10(7):1533. doi: 10.3390/jcm10071533. J Clin Med. 2021. PMID: 33917484 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous